MIMS Hosted

MIMS is pleased to announce a new section, MIMS Hosted , which provides healthcare professionals with access to relevant resources produced by external organisations.

If you would like to reach our audience of GPs, nurses and pharmacists by hosting your resource(s) in print, video or audio format on MIMS Hosted, please contact our team via our advertising and sponsorship page. Content must be compliant with MIMS editorial standards.


Dr Reddy's UK launches the first available lacidipine 6mg tablets

Content supplied by Dr. Reddy’s UK

Dr. Reddy’s UK is delighted to announce the first available Lacidipine 6mg Film-Coated Tablets to its expanding product portfolio. Lacidipine 6mg is an additional strength to its currently available Lacidipine 2mg and 4mg strengths, which have been available since 2014.

Lacidipine is indicated in adults for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors.

Lacidipine Film-Coated Tablets are presented in 2mg, 4mg and 6mg strengths, packed in a calendar unit dose blister of 28 tablets and are available from your local wholesaler or by contacting Dr. Reddy’s at 01482 389858 or customerserviceuk@drreddys.com.

Download lacidipine 6mg leaflet

View lacidipine 6mg prescribing information

DRL0340; Date of preparation May 2020

Resist the Resistance

Content supplied by Advanz Pharma

Manage lower UTIs with MacroBID®, a low-resistance, NICE-recommended treatment for lower UTIs.1

MacroBID® is indicated for the treatment of and prophylaxis against acute or recurrent, uncomplicated lower UTIs or pyelitis either spontaneous or following surgical procedures, in patients over 12 years of age.2

Download the MacroBID® leave piece

View MacroBID® prescribing information

References:

  1. NICE. Urinary tract infection (lower): antimicrobial prescribing (NG109). Published 31 October 2018.
  2. MacroBID® (nitrofurantoin 100 mg prolonged-release capsules) Summary of Product Characteristics. ADVANZ Pharma, 25 March 2019.

ADV/MAB/PM/0176; Date of preparation April 2020

Help eczema patients minimise the risk of infection

Content supplied by Alliance Pharmaceuticals Ltd

Using wound care treatments in a tube can contribute to reducing the risk of contamination and infection.1 Hydromol ® Ointment is the first 3-in-1 ointment in a tube. It comes in a handy 100g travel size - ideal for air travel. It also offers better dosing control, allowing less product wastage.2

Whilst ensuring patients have the best care, you are also having a positive effect on the NHS drugs budget! Wound care causes patients immeasurable hardship and distress, and costs the NHS billions every year.3

Download Hydromol Ointment in a Tube patient leaflet
This leaflet can be printed and provided to your patients to help them understand how Hydromol Ointment can help them manage their eczema, psoriasis and other dry skin conditions. 

References:

  1. Sibbald RG, et al. Ostomy Wound Manage 2003; 49(11): 24-51.
  2. Available at www.etma-online.org , last accessed March 2019.
  3. Available at pressureinjuryprevention.com/uk-wound-care-cost/ , last accessed March 2020.

JB-000282; Date of preparation March 2020

App to help your patients 'Living with Eczema'

Content supplied by Alliance Pharmaceuticals Ltd

Healthcare apps can play an important role in engaging patients in their own health care and increasing patient empowerment.1 The Living with Eczema App has been launched to provide patients with general information about eczema, together with tools to help them manage their delicate eczema skin successfully. It offers a Skin Diary and Photo Journal to track changes in their condition. They can also set useful Treatment and Appointment reminders.

Advise your patients to search 'Living with Eczema' in the App Store or on Google Play and download it for free.

Download Eczema App Flyer
This flyer can be printed and provided to your patients to explain how the Living With Eczema App can help them manage their eczema, psoriasis and other dry skin conditions. 

Reference:

  1. Vo V et al. JMIR Mhealth Uhealth 2019 Jul; 7(7): e13817.

JB-000282; Date of preparation March 2020

Simple Steps

Content supplied by Thornton & Ross

View Simple Steps leaflet
T&R SS 005 11.19; November 2019

View Simple Steps editorial
T&R SS 004 11.19; November 2019

'Simple Steps', a foot health campaign from Flexitol, provides materials for people with diabetes to support them to maintain healthy feet. These include a leaflet which outlines a simple, daily, foot care routine and advice on how to identify foot conditions, as well as an editorial written by an advanced podiatrist on the importance of establishing a daily foot care routine, finding out level of risk and when to visit a healthcare professional.

The 'Simple Steps' materials can be printed and provided to your patients with diabetes, to help them understand how to maintain a healthy foot care routine and prevent the development of complications.